For the past 36 years, many low-income Filipino women relied on contraceptive supplies provided for free from government facilities in order to delay or space their pregnancies. When the donations of free contraceptives from USAID were phased out, there was concern that the family planning needs of many Filipinos would no longer be met. There was fear that the already low contraceptive prevalence rate of 49.3 percent would further decline.
 
Through a simple market analysis, USAID helped three pharmaceutical companies realize the opportunity created by the supply gap from the phase out. The three companies invested in market entry, intensive promotion, sale and distribution of three low-priced oral contraceptives and an injectable.
 
Sales of the four USAID-supported products increased significantly from 731,000 cycles in 2006 to approximately 2.9 million in 2008. Today, one out of two women obtains her contraceptive supplies from the private sector compared to just one out of three in 2004.